BridgeBio Pharma, Inc.
BBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001743881
In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 5 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in BridgeBio Pharma, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 462
- +35 vs. Q4 2025
- Shares held
- 194.7M
- +21.6M (+12.5%) vs. Q4 2025
- Total value
- $14.4B
- +$1.39B (+10.6%) vs. Q4 2025
- New holders
- 90
- 185 more added
- Sold out
- 55
- 134 more reduced
8 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 475 | $14.4B |
| Q1 2026 | 462 | $14.4B |
| Q4 2025 | 435 | $14.4B |
| Q3 2025 | 392 | $9.62B |
| Q2 2025 | 359 | $8.15B |
| Q1 2025 | 304 | $6.45B |
| Q4 2024 | 263 | $4.85B |
| Q3 2024 | 254 | $4.39B |
| Q2 2024 | 251 | $4.43B |
| Q1 2024 | 244 | $5.31B |
| Q4 2023 | 247 | $6.69B |
| Q3 2023 | 221 | $4.24B |
| Q2 2023 | 197 | $2.58B |
| Q1 2023 | 213 | $2.53B |
| Q4 2022 | 179 | $1.10B |
| Q3 2022 | 181 | $1.44B |
| Q2 2022 | 165 | $1.28B |
| Q1 2022 | 179 | $1.45B |
| Q4 2021 | 195 | $2.37B |
| Q3 2021 | 212 | $6.56B |
| Q2 2021 | 201 | $8.70B |
| Q1 2021 | 199 | $8.69B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding BridgeBio Pharma, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Forum Financial Management, LP | 0 | $0 | 0.00% | −3,604−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −3,600−100.0% | Sold out |
| Sequoia Financial Advisors, LLC | 0 | $0 | 0.00% | −3,134−100.0% | Sold out |
| Torno Capital, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −2,344−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −696−100.0% | Sold out |
| Chung Wu Investment Group, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Vermillion & White Wealth Management Group, LLC | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| Turning Point Benefit Group, Inc. | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Rakuten Securities, Inc. | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Greenline Wealth Management LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Optima Capital LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| DV Trading LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |
| Southport Management, L.L.C. | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| ORG Partners LLC | – | – | – | – | Not filed |